التفاصيل البيبلوغرافية
| العنوان: |
Phase Ib study of gevokizumab (GEVO) in combination with standard-of-care (SoC) anticancer therapies in patients (pts) with metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC), and metastatic renal cell cancer (mRCC). |
| المؤلفون: |
Starling, Naureen, Shitara, Kohei, Kiss, Igor, Santoro, Armando, Goetze, Thorsten O., Chen, Eric Xueyu, Masuishi, Toshiki, McKean, Meredith, Wainberg, Zev A., Folprecht, Gunnar, Kimura, Go, Jonasch, Eric, Flesch, Carole, Xu, Virginia, Bento Pereira da Silva, Ana, Sareen, Rajan, Gregory, John, Van Cutsem, Eric |
| المصدر: |
Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p135-135, 307p |
| قاعدة البيانات: |
Supplemental Index |